PLATELET GLYCOPROTEIN IIB/IIIA RECEPTOR ANTAGONIST USE FOR NSTEACS: A REVIEW TO PATIENT SELECTION
Ahmed Mohammed Farhat;
Abstract
The aim of this study is to compare patients of NSTEACS (at low or intermediate risk) who were given GP IIb/IIIa antagonist (Tirofiban) and those who were not; to evaluate benefits gained both angiographically and clinically ( major adverse cardiac events
Other data
| Title | PLATELET GLYCOPROTEIN IIB/IIIA RECEPTOR ANTAGONIST USE FOR NSTEACS: A REVIEW TO PATIENT SELECTION | Other Titles | دراسة لتحديد المرضى الأكثر استفادة من مضادات مستقبلات البروتين السكري 2ب/3أ في حالات القصور الحاد بالشرايين التاجية غير المصحوب بارتفاع قطعة إس تي | Authors | Ahmed Mohammed Farhat | Keywords | PLATELET GLYCOPROTEIN IIB/IIIA RECEPTOR ANTAGONIST USE FOR NSTEACS: A REVIEW TO PATIENT SELECTION | Issue Date | 2010 | Description | The aim of this study is to compare patients of NSTEACS (at low or intermediate risk) who were given GP IIb/IIIa antagonist (Tirofiban) and those who were not; to evaluate benefits gained both angiographically and clinically ( major adverse cardiac events |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 95592p529.pdf | 618.89 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.